Venezuela Sample Import for Registration: Three Channels and Their Thresholds

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Samples intended for registration testing can move through the non-commercial sample channel and benefit from the exception to non-tariff restrictions. The test is that quantity, nature and value must not constitute a commercial purpose, and prior authorization must be obtained from the customs office at the port of entry. Separately, samples of no commercial value and personal effects with an FOB value not exceeding US$100 are exempt from express declaration and from import duties and taxes.

The conclusion is that the key to the sample channel is prior authorization, not after-the-fact explanation. Where a consignment is shipped as samples without prior authorization from the entry customs office, customs is entitled to treat it as an ordinary import, and regularizing the position afterwards is far more complicated than applying in advance. The difference is not administrative convenience; it is the difference between a consignment that clears and one that sits at port while the file is rebuilt.

This matters most in the early phase of a project, when samples are needed for testing but the registration file does not yet exist. That is precisely the moment when documentation is thinnest and when the temptation to ship first and explain later is strongest.

2. Legal basis

InstrumentReferencePublication dateProvision / point
Exception to non-tariff restrictions for samplesUSDA GAIN report VE2026-0007 (Caracas)July 2026Samples for registration, testing, research, verification or analysis do not fall under non-tariff restrictions where quantity, nature and value do not constitute a commercial purpose; prior authorization from the entry customs office is required
Declaration-free threshold for samples of no commercial valueUSDA GAIN report VE2026-0007 (Caracas)July 2026Samples and personal effects with an FOB value not exceeding US$100.00 are exempt from express declaration and from import duties and taxes
Restoration of the courier regimeUSDA GAIN report VE2025-0010 (Caracas)July 2025The courier regime was restored on July 15, 2023, with an FOB cap of US$2,000 per courier waybill
Circular N° DGSACS-008/2026DGSACS-008/2026July 9, 2026Time limit for submitting the application before the arrival of the goods

Source note: the thresholds and regimes above are drawn from USDA Foreign Agricultural Service GAIN country reports. They are a third-party official source, not Venezuelan domestic legal text, and the source level must be stated whenever they are cited.

3. Expert insights

Insight 1: the two thresholds serve different purposes and should not be mixed. The US$100 threshold is a declaration and duty threshold, operating as a clearance facilitation. The non-commercial purpose test is a non-tariff restriction exception threshold, operating at the level of the admission obligation. Most registration test samples exceed US$100 — a single device unit routinely runs into thousands of dollars — and in that case the correct route is the second one, not the assumption that no facilitation is available at all.

Insight 2: the courier regime provides a third route for small consignments. The courier regime was restored on July 15, 2023 and applies to letters, documents and parcels, with an FOB cap of US$2,000 per courier waybill, using a door-to-door consolidation model for rapid clearance. Reagents, consumables and small device samples within that limit can be considered for this channel. Consignments above US$2,000 follow the ordinary import procedure.

Insight 3: Circular DGSACS-008/2026 emphasizes submitting the application before the goods arrive. The circular states that SACS can respond within a defined time limit and before the arrival of the goods. This applies to samples as well: completing the application before dispatch rather than after the goods reach port is the key to avoiding demurrage and storage cost. The cost of port delay usually exceeds the value of the samples themselves, which makes advance filing an economic decision and not only a compliance one.

A fourth consideration is documentation of the testing rationale. The quantity shipped has to be explainable by the test protocol, and the explanation has to exist at the time of import rather than being reconstructed afterwards. Where the protocol is written by the testing laboratory, obtaining it before dispatch is straightforward; where it does not exist in writing, the consignment has no defensible basis for its size.

Channel selection should also be revisited per consignment rather than fixed once for a program. A first shipment of engineering units, a second shipment of production-equivalent units for validation testing and a third shipment of retention samples have different values, different urgencies and different documentary profiles. Treating them as a single recurring process usually means applying the most conservative channel to all three, which is safe but slow, or the fastest channel to all three, which is neither.

Retention of records deserves the same planning as the shipment itself. The authorization, the acknowledgement, the invoice showing the declared value and the internal document linking the units to a test protocol should sit in one place and be retrievable by consignment. Where these are scattered across freight forwarder, customs broker and testing laboratory, reconstructing the position during a query takes longer than the clearance did.

4. Practical recommendations

  1. Set rules for choosing among the three channels: FOB of US$100 or less goes through the declaration-free route; FOB of US$2,000 or less goes through the courier regime; everything else goes as non-commercial samples with prior customs authorization.
  2. Submit the prior authorization application to the entry customs office before dispatch and retain the acknowledgement of receipt as part of the file.
  3. Set the sample quantity at the minimum necessary under the test plan, and explain in the accompanying documents how that quantity maps onto the individual test items.
  4. Build the dispatch date into the project schedule and link it to the testing laboratory’s availability, so that samples do not sit at port waiting for a slot that was never booked.

5. Verification checklist

  • □ The correct channel has been selected by FOB value: declaration-free, courier or non-commercial sample authorization
  • □ Prior authorization from the entry customs office has been obtained and the receipt retained
  • □ Sample quantities match the minimum necessary under the test plan and are explained in writing
  • □ The application was completed before the arrival of the goods in line with Circular DGSACS-008/2026
  • □ Dispatch timing has been coordinated and confirmed with the testing laboratory’s schedule

Regulatory information verified as of October 29, 2026.

GRZAN provides registration support in Venezuela for manufacturers, importers and authorized representatives, including sample channel selection, prior authorization coordination and testing logistics planning. For scope and document requirements, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail